Clinical trials recruiting for Prader-Willi Syndrome

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study of CSTI-500 in Patients With Prader-Willi Syndrome
  NCT07348601 · Phase: Phase 2 · Ages: 13 Years to 50 Years · Sex: All (male and female) · 1 location
• A Study of Pitolisant in Patients With Prader-Willi Syndrome
  NCT06366464 · Phase: Phase 3 · Ages: 6 Years and older · Sex: All (male and female) · 57 locations
• A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
  NCT06239116 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 65 Years · Sex: All (male and female) · 7 locations
• Autistic Symptomatology and Sensory Profile in Children With Prader-Willi Syndrome
  NCT06877715 · Phase: Not specified · Ages: 3 Years to 16 Years · Sex: All (male and female) · 1 location
• Cerebellar TMS and Satiety in Prader-Willi Syndrome
  NCT05938543 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• Effects of Transcutaneous Vagus Nerve Stimulation on Emotion Regulation and Executive Functioning in Prader-Willi Syndrome
  NCT06720571 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• GROWing Up With Rare GENEtic Syndromes
  NCT04463316 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
  NCT05945576 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 20 locations
• Impact of Bright Light Therapy on Prader-Willi Syndrome
  NCT05939453 · Phase: Not applicable (e.g. observational or device study) · Ages: 6 Years to 88 Years · Sex: All (male and female) · 1 location
• Institutional Registry of Rare Diseases
  NCT06573723 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Physical Activity and Community EmPOWERment Project
  NCT06740162 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Register of Patients With Prader-Willi Syndrome
  NCT02829684 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion Dysregulation
  NCT07607730 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 17 Years · Sex: All (male and female) · 1 location
• The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics
  NCT05791604 · Phase: Not applicable (e.g. observational or device study) · Ages: 3 Years to 10 Years · Sex: All (male and female) · 1 location
• Tirzepatide in PWS, HO and GNSO
  NCT06901245 · Phase: Phase 4 · Ages: 18 Years to 26 Years · Sex: All (male and female) · 3 locations

Related conditions

Trials recruiting for Prader-Willi Syndrome often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Prader-Willi Syndrome trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.